Roopal V. Kundu

Jan 17, 2024 | jamanetwork.com | Roopal V. Kundu |Neelam A. Vashi |Oyinade Aderibigbe |Julia Riley

Potential Role of Tranexamine Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation—Reply In Reply We thank Hashemi et al for their engagement and thoughtful reply to our article1 that highlighted their experience with tranexamic acid (TA) and procedural therapies. We agree that treatment approaches in hyperpigmentation have had great advancements.

Jan 17, 2024 | jamanetwork.com | David A. Hashemi |Jordan V. Wang |Roy G. Geronemus |Roopal V. Kundu

Potential Role of Tranexamine Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation To the Editor In reading the recent article by Kundu et al1 regarding the management of facial hyperpigmentation due to melasma and postinflammatory hyperpigmentation (PIH), we have additional perspectives regarding medical and procedural management given recent advancements described in the literature and our own clinical experience.